Danijela Miljanovic
Overview
Explore the profile of Danijela Miljanovic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
234
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Banko A, Lazarevic I, Miljanovic D, Cupic M, Cirkovic A
Microorganisms
. 2024 Nov;
12(11).
PMID: 39597507
Colorectal cancer (CRC) is one of the most common types of cancer worldwide. In addition to known risk factors, oncoviruses have attracted exceptional attention from recent research. Numerous hypotheses on...
2.
Lazarevic I, Miljanovic D, Banko A, Cupic M, Cirkovic A
Viruses
. 2024 Jul;
16(7).
PMID: 39066283
During chronic hepatitis B virus (HBV) infection, the seroclearance of hepatitis B e antigen (HBeAg) is an important event and a significant surrogate endpoint of all current therapeutic strategies. The...
3.
Vasiljevic T, Jankovic M, Tomic A, Bakrac I, Radenovic S, Miljanovic D, et al.
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675390
Introduction: Cytomegalovirus (CMV) infection is a major clinical issue after allogeneic hematopoietic stem cell transplantation (HSCT). The CMV envelope glycoproteins are key in viral pathogenesis; the glycoprotein B (gB) encoded...
4.
Lazarevic I, Banko A, Miljanovic D, Cupic M
Pathogens
. 2024 Jan;
13(1).
PMID: 38251353
The hepatitis B surface antigen (HBsAg) is a multifunctional glycoprotein composed of large (LHB), middle (MHB), and small (SHB) subunits. HBsAg isoforms have numerous biological functions during HBV infection-from initial...
5.
Banko A, Cirkovic A, Miskovic R, Jeremic I, Grk M, Basaric M, et al.
Front Immunol
. 2023 Dec;
14:1307589.
PMID: 38146370
Introduction: The relationship between Systemic lupus erythematosus (SLE) and Epstein-Barr virus (EBV) infection has been suggested for decades, but the underlying mechanism of the EBV influence on SLE development remains...
6.
Banko A, Cirkovic A, Jeremic I, Basaric M, Grk M, Miskovic R, et al.
Biomedicines
. 2023 Sep;
11(9).
PMID: 37760816
Epstein-Barr virus (EBV) infection has been shown as a potential risk factor for the development of rheumatoid arthritis (RA). This prospective research aimed to investigate whether EBV infection markers changed...
7.
Miljanovic D, Cirkovic A, Jermic I, Basaric M, Lazarevic I, Grk M, et al.
Microorganisms
. 2023 Aug;
11(8).
PMID: 37630516
Although the connection between Epstein-Barr virus (EBV) and rheumatoid arthritis (RA) has been studied for over 40 years, many questions still need clarification. The study aimed to analyze the possible...
8.
Grk M, Miskovic R, Jeremic I, Basaric M, Dusanovic Pjevic M, Jekic B, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511050
Systemic lupus erythematosus (SLE) is characterized by an imbalance between proinflammatory and anti-inflammatory mediators. Single-nucleotide polymorphisms (SNPs) in genes coding , , and could affect their expression or function and...
9.
Miskovic R, Cirkovic A, Miljanovic D, Jeremic I, Grk M, Basaric M, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047126
Although Epstein-Barr virus (EBV) reactivation has long been associated with the pathogenesis of systemic lupus erythematosus (SLE), many aspects of this relationship remain unclear. Our objective was to investigate the...
10.
Miljanovic D, Cirkovic A, Lazarevic I, Knezevic A, Cupic M, Banko A
Rev Med Virol
. 2023 Mar;
33(4):e2439.
PMID: 36924087
Until now, the treatment protocols for COVID-19 have been revised multiple times. The use and approval of therapeutic monoclonal antibodies (mAbs) for COVID-19 treatment represent exceptional achievements in modern science,...